Payment overview · 2025
General Payments
$286.61
4 reported records · 4 companies
Healthcare provider profile · identity verified
Gregory Todd, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · ALLENTOWN, PA · NPI 1376590661
Verified facts
What the public records show
CMS Open Payments records show Gregory Todd, D.O. received $286.61 in general payments during 2025 across 4 reported records.
Alkermes, Inc. accounted for 43.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 133 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $124.74 | 43.5% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $124.74 | 43.5% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $19.08 | 6.7% | 1 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $18.05 | 6.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $286.61 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $124.74 | 1 | 2025 |
Source payment records
|
|||||
| VIVITROL Normalized: vivitrol |
Drug | Alkermes, Inc. | $124.74 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $19.08 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $19.08 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $19.08 | 1 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $18.05 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
133 | 31 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 572 | 145 |
| Amlodipine Besylate | Amlodipine Besylate | 562 | 165 |
| Atorvastatin Calcium | Atorvastatin Calcium | 406 | 117 |
| Lisinopril | Lisinopril | 374 | 115 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 325 | 89 |
| Simvastatin | Simvastatin | 315 | 89 |
| Gabapentin | Gabapentin | 308 | 88 |
| Metformin Hcl | Metformin Hcl | 302 | 90 |
| Metoprolol Succinate | Metoprolol Succinate | 247 | 77 |
| Omeprazole | Omeprazole | 236 | 80 |
| Pantoprazole Sodium | Pantoprazole Sodium | 187 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 181 | 53 |
| Meloxicam | Meloxicam | 181 | 63 |
| Lorazepam | Lorazepam | 179 | 50 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 159 | 48 |
| Zolpidem Tartrate | Zolpidem Tartrate | 149 | 46 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 148 | 42 |
| Sertraline Hcl | Sertraline Hcl | 148 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 141 | 39 |
| Losartan Potassium | Losartan Potassium | 139 | 44 |
| Eliquis | Apixaban | 133 | 31 |
| Furosemide | Furosemide | 133 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 133 | 32 |
| Jardiance | Empagliflozin | 124 | 27 |
| Trazodone Hcl | Trazodone Hcl | 120 | 32 |
| Glimepiride | Glimepiride | 119 | 37 |
| Alprazolam | Alprazolam | 115 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 113 | 33 |
| Montelukast Sodium | Montelukast Sodium | 113 | 36 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 107 | 32 |
| Torsemide | Torsemide | 107 | 33 |
| Azithromycin | Azithromycin | 105 | 85 |
| Duloxetine Hcl | Duloxetine Hcl | 105 | 30 |
| Tramadol Hcl | Tramadol Hcl | 103 | 25 |
| Amoxicillin | Amoxicillin | 99 | 65 |
| Oxycodone Hcl | Oxycodone Hcl | 98 | 15 |
| Prednisone | Prednisone | 98 | 78 |
| Bupropion Xl | Bupropion Hcl | 97 | 33 |
| Allopurinol | Allopurinol | 96 | 28 |
| Cephalexin | Cephalexin | 95 | 55 |
| Potassium Chloride | Potassium Chloride | 90 | 28 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 89 | 17 |
| Atenolol | Atenolol | 83 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 79 | 31 |
| Pravastatin Sodium | Pravastatin Sodium | 75 | 21 |
| Xarelto | Rivaroxaban | 75 | 17 |
| Clonazepam | Clonazepam | 73 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 68 | 23 |
| Levofloxacin | Levofloxacin | 68 | 54 |
| Celecoxib | Celecoxib | 66 | 26 |
| Pregabalin | Pregabalin | 63 | 16 |
| Synthroid | Levothyroxine Sodium | 63 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | 17 |
| Methocarbamol | Methocarbamol | 59 | 28 |
| Warfarin Sodium | Warfarin Sodium | 59 | 13 |
| Mounjaro | Tirzepatide | 57 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 57 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 55 | 46 |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 17 |
| Naproxen | Naproxen | 54 | 12 |
| Ezetimibe | Ezetimibe | 52 | 15 |
| Carvedilol | Carvedilol | 51 | 12 |
| Myrbetriq | Mirabegron | 49 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 16 |
| Ozempic | Semaglutide | 48 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 46 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Spironolactone | Spironolactone | 45 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 45 | 16 |
| Methylprednisolone | Methylprednisolone | 43 | 40 |
| Famotidine | Famotidine | 41 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 25 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | 13 |
| Mometasone Furoate | Mometasone Furoate | 38 | 27 |
| Mirtazapine | Mirtazapine | 37 | suppressed |
| Linzess | Linaclotide | 36 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 34 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 34 | suppressed |
| Cefdinir | Cefdinir | 33 | 28 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 32 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 32 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 31 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 31 | 12 |
| Risperidone | Risperidone | 31 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 28 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 28 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 27 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Baclofen | Baclofen | 25 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 23 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 22 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Aripiprazole | Aripiprazole | 19 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 19 | 11 |
| Buspirone Hcl | Buspirone Hcl | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 11 |
| Nystatin | Nystatin | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Ofloxacin | Ofloxacin | 14 | 13 |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Silodosin | Silodosin | 14 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Desloratadine | Desloratadine | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Inderal La | Propranolol Hcl | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Methadone Hcl | Methadone Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $286.61 · 4 records | Alkermes, Inc. | ABRYSVO, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, CAPVAXIVE, COMIRNATY, PREVNAR 20, VIVITROL | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with PFIZER INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error